AKT1 and melanoma: Hamai et al further emphasized the role of ICAM1 in immune resistance by showing that reduced expression of ICAM1 in metastatic melanoma, as compared to primary melanoma, was associated with decreased PTEN activity and activation of PI3K/AKT pathway, leading to reduced apoptosis [39].